Literature DB >> 31733829

Proximal tubule cyclophilin D regulates fatty acid oxidation in cisplatin-induced acute kidney injury.

Hee-Seong Jang1, Mi Ra Noh2, Eui-Man Jung3, Woo-Yang Kim4, Siddesh Southekal5, Chittibabu Guda5, Kirk W Foster6, David Oupicky7, Fernando A Ferrer8, Babu J Padanilam9.   

Abstract

Regardless of the etiology, acute kidney injury involves aspects of mitochondrial dysfunction and ATP depletion. Fatty acid oxidation is the preferred energy source of the kidney and is inhibited during acute kidney injury. A pivotal role for the mitochondrial matrix protein, cyclophilin D in regulating overall cell metabolism is being unraveled. We hypothesize that mitochondrial interaction of proximal tubule cyclophilin D and the transcription factor PPARα modulate fatty acid beta-oxidation in cisplatin-induced acute kidney injury. Cisplatin injury resulted in histological and functional damage in the kidney with downregulation of fatty acid oxidation genes and increase of intrarenal lipid accumulation. However, proximal tubule-specific deletion of cyclophilin D protected the kidneys from the aforementioned effects. Mitochondrial translocation of PPARα, its binding to cyclophilin D, and sequestration led to inhibition of its nuclear translocation and transcription of PPARα-regulated fatty acid oxidation genes during cisplatin-induced acute kidney injury. Genetic or pharmacological inhibition of cyclophilin D preserved nuclear expression and transcriptional activity of PPARα and prevented the impairment of fatty acid oxidation and intracellular lipid accumulation. Docking analysis identified potential binding sites between PPARα and cyclophilin D. Thus, our results indicate that proximal tubule cyclophilin D elicits impaired mitochondrial fatty acid oxidation via mitochondrial interaction between cyclophilin D and PPARα. Hence, targeting their interaction may be a potential therapeutic strategy to prevent energy depletion, lipotoxicity and cell death in cisplatin-induced acute kidney injury.
Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATP depletion; acute kidney injury; chemotherapy; cisplatin nephrotoxicity; mitochondria; proximal tubule

Mesh:

Substances:

Year:  2019        PMID: 31733829      PMCID: PMC6983334          DOI: 10.1016/j.kint.2019.08.019

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  56 in total

Review 1.  Oxidant Mechanisms in Renal Injury and Disease.

Authors:  Brian B Ratliff; Wasan Abdulmahdi; Rahul Pawar; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2016-04-26       Impact factor: 8.401

Review 2.  Mitochondrial permeability transition pore is a potential drug target for neurodegeneration.

Authors:  Valasani Koteswara Rao; Emily A Carlson; Shirley Shidu Yan
Journal:  Biochim Biophys Acta       Date:  2013-09-18

3.  Metabolomic study of cisplatin-induced nephrotoxicity.

Authors:  D Portilla; S Li; K K Nagothu; J Megyesi; B Kaissling; L Schnackenberg; R L Safirstein; R D Beger
Journal:  Kidney Int       Date:  2006-05-03       Impact factor: 10.612

4.  Fibrate prevents cisplatin-induced proximal tubule cell death.

Authors:  Kiran K Nagothu; Renu Bhatt; Gur P Kaushal; Didier Portilla
Journal:  Kidney Int       Date:  2005-12       Impact factor: 10.612

5.  Fasting plasma lipid measurements following cisplatin chemotherapy in patients with germ cell tumors.

Authors:  P A Ellis; B M Fitzharris; P M George; B A Robinson; C H Atkinson; B M Colls
Journal:  J Clin Oncol       Date:  1992-10       Impact factor: 44.544

Review 6.  Energy metabolism and cytotoxicity.

Authors:  Didier Portilla
Journal:  Semin Nephrol       Date:  2003-09       Impact factor: 5.299

Review 7.  Regulation of necrotic cell death: p53, PARP1 and cyclophilin D-overlapping pathways of regulated necrosis?

Authors:  Yuan Ying; Babu J Padanilam
Journal:  Cell Mol Life Sci       Date:  2016-04-05       Impact factor: 9.261

8.  Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure.

Authors:  Shiang Y Lim; Derek J Hausenloy; Sapna Arjun; Anthony N Price; Sean M Davidson; Mark F Lythgoe; Derek M Yellon
Journal:  J Cell Mol Med       Date:  2011-11       Impact factor: 5.310

9.  A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin.

Authors:  G J Veal; M J Griffin; E Price; A Parry; G S Dick; M A Little; S M Yule; B Morland; E J Estlin; J P Hale; A D Pearson; H Welbank; A V Boddy
Journal:  Br J Cancer       Date:  2001-04-20       Impact factor: 7.640

Review 10.  Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases.

Authors:  Zaza Khuchua; Aleksandr I Glukhov; Arnold W Strauss; Sabzali Javadov
Journal:  Int J Mol Sci       Date:  2018-11-04       Impact factor: 5.923

View more
  15 in total

1.  Hepatic and proximal tubule angiotensinogen play distinct roles in kidney dysfunction, glomerular and tubular injury, and fibrosis progression.

Authors:  Hee-Seong Jang; Mi Ra Noh; Troy Plumb; Kyung Lee; John Cijiang He; Fernando A Ferrer; Babu J Padanilam
Journal:  Am J Physiol Renal Physiol       Date:  2022-08-04

2.  Proximal tubule cyclophilin D mediates kidney fibrogenesis in obstructive nephropathy.

Authors:  Hee-Seong Jang; Mi Ra Noh; Ligyeom Ha; Jinu Kim; Babu J Padanilam
Journal:  Am J Physiol Renal Physiol       Date:  2021-08-16

3.  Receptor of Advanced Glycation End Products Deficiency Attenuates Cisplatin-Induced Acute Nephrotoxicity by Inhibiting Apoptosis, Inflammation and Restoring Fatty Acid Oxidation.

Authors:  Qiang Wang; Yuemei Xi; Binyang Chen; Hairong Zhao; Wei Yu; Weidong Liu; Furong He; Chenxi Xu; Jidong Cheng
Journal:  Front Pharmacol       Date:  2022-05-30       Impact factor: 5.988

4.  Short-term control of diet affects cisplatin-induced acute kidney injury through modulation of mitochondrial dynamics and mitochondrial GSH.

Authors:  Ji Su Kim; Yong Kwon Han; Min Jung Kong; Kwon Moo Park
Journal:  Physiol Rep       Date:  2022-06

Review 5.  The role of metabolic reprogramming in tubular epithelial cells during the progression of acute kidney injury.

Authors:  Zhenzhen Li; Shan Lu; Xiaobing Li
Journal:  Cell Mol Life Sci       Date:  2021-06-29       Impact factor: 9.261

6.  Discovery of preventive drugs for cisplatin-induced acute kidney injury using big data analysis.

Authors:  Masaya Kanda; Mitsuhiro Goda; Akiko Maegawa; Toshihiko Yoshioka; Ami Yoshida; Koji Miyata; Fuka Aizawa; Takahiro Niimura; Hirofumi Hamano; Naoto Okada; Takumi Sakurada; Masayuki Chuma; Kenta Yagi; Yuki Izawa-Ishizawa; Hiroaki Yanagawa; Yoshito Zamami; Keisuke Ishizawa
Journal:  Clin Transl Sci       Date:  2022-04-30       Impact factor: 4.438

Review 7.  Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Kiavash Hushmandi; Mahshad Kalantari; Reza Mohammadinejad; Tahereh Javaheri; Gautam Sethi
Journal:  Int J Mol Sci       Date:  2020-06-03       Impact factor: 5.923

8.  IFT88 deficiency in proximal tubular cells exaggerates cisplatin-induced injury by suppressing autophagy.

Authors:  Shixuan Wang; Shougang Zhuang; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2021-07-12

Review 9.  Defective Mitochondrial Fatty Acid Oxidation and Lipotoxicity in Kidney Diseases.

Authors:  Hee-Seong Jang; Mi Ra Noh; Jinu Kim; Babu J Padanilam
Journal:  Front Med (Lausanne)       Date:  2020-03-12

Review 10.  Dyslipidemia in Kidney Disorders: Perspectives on Mitochondria Homeostasis and Therapeutic Opportunities.

Authors:  Pei-Hui Lin; Pu Duann
Journal:  Front Physiol       Date:  2020-09-03       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.